Global Psychedelic therapeutics market is projected to grow at an annualized rate of ~15%, till 2030

Roots Analysis has done a detailedstudy on Global Psychedelic TherapeuticsMarket, 2020-2030” covering key aspects of the industry and identifyingpotential future growth opportunities

To order this 250+page report, which features 120+ figures and 135+ tables, please visit this- https://www.rootsanalysis.com/reports/global-psychedelic-therapeutics-market.html

Key Market Insights

§  Nearly 70 playersfrom across the world presently claim to be engaged in the development andevaluation of therapeutic candidates based on a number of psychedeliccompounds, such as ketamine and psilocybin

§  The pipeline featuresproduct candidates based on a variety of psychedelic drug classes, which arebeing investigated for a wide range of target disease indications, and havingdifferent routes of administration

§  From a globalperspective, this industry is anticipated to evolve significantly over the nextfew years as federal / regional regulators in different nations are graduallyconvinced of the clinical significance of this product class

§  Severalorganizations, having realized the untapped opportunity within this emergingsegment of psychedelic therapeutics, have awarded grants of over USD 275million across 500+ instances between 2015-2020

§  Several trials evaluating various psychedelic compounds against a widerange of therapeutic indication have been registered in the recent past

§  The growing interestis also reflected in the partnership activity since 2017; a number of differenttypes of deals involving various drug classes have been established acrossmultiple geographies

§  Presently, NorthAmerican companies are actively consolidating their indigenous presence throughstrategic acquisitions; key value drivers behind such deals include bothportfolio and geographical expansion

§  A number of eminentscientists from renowned universities have emerged as key opinion leaders inthis domain, owing to their active involvement in clinical development effortsrelated to interventions based on psychedelics

§  Future market size,based on revenue reported from the sales of marketed and late stagepsychedelic-based  therapies, isanticipated to be distributed across different therapeutic areas and keygeographical regions

For more information, please visit https://www.rootsanalysis.com/reports/global-psychedelic-therapeutics-market.html

Table of Contents

1.                     PREFACE

1.1.                  Scopeof the Report

1.2.                  ResearchMethodology

1.3.                  ChapterOutlines

2.                     EXECUTIVESUMMARY

3.                     INTRODUCTION

3.1.                  ChapterOverview

3.2.                  Historyof Psychedelic Substance

3.3.                  PotentialTherapeutic Application of Psychedelic Substance

3.4.                  Regulation, Toxicity Concerns,Procurement-Related Challenges and Perceptions Regarding Medical Use

3.5.                  FutureOpportunity

4.                     MARKETLANDSCAPE: PSYCHEDELIC THERAPEUTICS

4.1.                  ChapterOverview

4.2.                  PsychedelicTherapeutics: Marketed and Development Pipeline

4.2.1.                Analysisby Phase of Development

4.2.2.                Analysisby Type of Psychedelic Substance

4.2.3.                Analysisby Origin of Psychedelic Substance

4.2.4.                Analysisby Target Therapeutic Area

4.2.5.                Analysisby Type of Therapy

4.2.6.                Analysisby Route of Administration

4.2.7.                Analysisby Dosing Frequency

4.3.                  PsychedelicTherapeutics: List of Developers

4.3.1.                Analysisby Year of Establishment

4.3.2.                Analysisby Company Size

4. 3.3.               Analysisby Location of Headquarters

4.4.                  Grid Analysis: Distribution byPhase of Development, Origin of Psychedelic Substance and Location ofHeadquarters